Last reviewed 2026-06-02 · How we verify

Cloronaftina (CHLORNAPHAZINE)

FDA-approved withdrawn Small molecule ✓ Verified Jun 2026 Quality 6/100

Cloronaftina (generic name: CHLORNAPHAZINE) is a drug. It is currently FDA-approved.

Cloronaftina is a small molecule with the synonyms CB 1048, CB-1048, CHLORNAPHAZINE, CLORNAFAZINA, NSC-62209, and R 48.

At a glance

Generic name	CHLORNAPHAZINE
Modality	Small molecule
Therapeutic area	Other
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Cloronaftina CI brief — competitive landscape report
Cloronaftina updates RSS · CI watch RSS

Frequently asked questions about Cloronaftina

What is Cloronaftina?

Cloronaftina (CHLORNAPHAZINE) is a Small molecule drug.

What is the generic name of Cloronaftina?

CHLORNAPHAZINE is the generic (nonproprietary) name of Cloronaftina.

What development phase is Cloronaftina in?

Cloronaftina is FDA-approved (marketed).

Therapeutic area: All drugs in Other

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing